Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer
Bioorganic & Medicinal Chemistry Letters · 2024
DOI: 10.1016/j.bmcl.2024.129795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Puneet Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and In…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents, Drug Screening Assays, Antitumor, Cell Proliferation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Chalcones are chemical scaffolds found in natural products, particularly in plants, and are considered for structural diversity in medicinal chemistry for drug development. Herein, we designed and synthesised novel acetamide derivatives of chalcone, characterizing them using 1H NMR, 13C NMR, HRMS, and IR spectroscopic methods. These derivatives were then screened against human cancer cells for cytotoxicity using the SRB assay. Among the tested derivatives, 7g, with a pyrrolidine group, exhibited better cell growth inhibition activity against triple-negative breast cancer (TNBC) cells. Further assays, including SRB, colony formation, and fluorescent dye-based microscopic analysis, confirmed that 7g significantly inhibited MDA-MB-231 cell proliferation. Furthermore, 7g promoted apoptosis by upregulating cellular reactive oxygen species (ROS) levels and disrupting mitochondrial membrane potential (MMP). Elevated expression of pro-apoptotic proteins (Bax and caspase-3) and a higher Bax/Bcl-2 ratio with downregulation of anti-apoptotic (Bcl-2) protein levels were observed in TNBC cells. The above results suggest that 7g can promote cellular death through apoptotic mechanisms in TNBC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Pharmacology Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India.
- Natural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India.
- Biotechnology Division, CSIR - Indian Institute of Integrative Medicine, Sanatnagar, Srinagar 190005, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Pharmacology Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: boobalan.g@iiim.res.in.
- Natural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address…
Zitieren
APA
Kumar, P., Singh, R., Sharma, D., Hassan, Q. P., Gopu, B., & Anal, J. M. H. (2024). Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2024.129795
Vancouver
Kumar P, Singh R, Sharma D, Hassan QP, Gopu B, Anal JMH. Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2024.129795
BibTeX
@article{Kumar2024,
author = {Kumar, Puneet and Singh, Ruhi and Sharma, Deepak and Hassan, Qazi Parvaiz and Gopu, Boobalan and Anal, Jasha Momo H},
title = {Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2024},
doi = {10.1016/j.bmcl.2024.129795}
}
EUVIMED